Related references
Note: Only part of the references are listed.Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: post hoc analysis of a randomized controlled trial
Sunao Kojima et al.
RHEUMATOLOGY (2022)
Classical Xanthinuria in Nine Israeli Families and Two Isolated Cases from Germany: Molecular, Biochemical and Population Genetics Aspects
Hava Peretz et al.
BIOMEDICINES (2021)
A novel mutation in xanthine dehydrogenase in a case with xanthinuria in Hunan province of China
Tao Xu et al.
CLINICA CHIMICA ACTA (2020)
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
Isla S. Mackenzie et al.
LANCET (2020)
Repeated measurements of serum urate and mortality: a prospective cohort study of 152,358 individuals over 8 years of follow-up
Shanshan Li et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Excess Deaths Upon Cessation of Xanthine Oxidase Inhibitor Treatment-Data From the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial: Comment on the Article by Choi et al
Michael R. Bubb
ARTHRITIS & RHEUMATOLOGY (2019)
Xanthine oxidase inhibitor withdrawal syndrome? Comment on the article by Choi et al
Todd A. Johnson et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Targeted knock-in mice expressing the oxidase-fixed form of xanthine oxidoreductase favor tumor growth
Teruo Kusano et al.
NATURE COMMUNICATIONS (2019)
Severe Hypouricemia Impairs Endothelium-Dependent Vasodilatation and Reduces Blood Pressure in Healthy Young Men: A Randomized, Placebo-Controlled, and Crossover Study
Benjamin De Becker et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert
Hyon Choi et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Putting xanthine oxidoreductase and aldehyde oxidase on the NO metabolism map: Nitrite reduction by molybdoenzymes
Luisa B. Maia et al.
REDOX BIOLOGY (2018)
Physiological functions and pathogenic potential of uric acid: A review
Rashika El Ridi et al.
JOURNAL OF ADVANCED RESEARCH (2017)
An unusual cause of pink diapers in an infant: Questions
Rasheda Amin et al.
PEDIATRIC NEPHROLOGY (2016)
Genes implicated in thiopurine-induced toxicity: Comparing TPMT enzyme activity with clinical phenotype and exome data in a paediatric IBD cohort
Tracy Coelho et al.
SCIENTIFIC REPORTS (2016)
A case of xanthinuria type I with a novel mutation in xanthine dehydrogenase
Akira Iguchi et al.
CEN CASE REPORTS (2016)
Xanthinuria Type I With a Novel Mutation of Xanthine Dehydrogenase
Ken-ichiro Tanaka et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2015)
Type 1 xanthinuria: Report on three cases
M. Diss et al.
ARCHIVES DE PEDIATRIE (2015)
Extremely Low Levels of Serum Uric Acid Are Associated With Endothelial Dysfunction in Humans
Tatsuya Iso et al.
CIRCULATION JOURNAL (2015)
Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis
Shulin Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout
Takeshi Nishino et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2015)
URIC ACID AND TISSUE REPAIR
Rodrigo Araldi Nery et al.
ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY (2015)
Xanthine oxidoreductase in atherosclerosis pathogenesis: Not only oxidative stress
Maria Giulia Battelli et al.
ATHEROSCLEROSIS (2014)
Multi-exon deletion in the XDH gene as a cause of classical xanthinuria
Thomas Eggermann et al.
CLINICAL NEPHROLOGY (2013)
Xanthine oxidoreductase-catalyzed reactive species generation: A process in critical need of reevaluation
Nadiezhda Cantu-Medellin et al.
REDOX BIOLOGY (2013)
Identification of a xanthinuria type I case with mutations of xanthine dehydrogenase in an Afghan child
Makiko Nakamura et al.
CLINICA CHIMICA ACTA (2012)
Novel mutations in xanthine dehydrogenase/oxidase cause severe hypouricemia: Biochemical and molecular genetic analysis in two Czech families with xanthinuria type I
Blanka Stiburkova et al.
CLINICA CHIMICA ACTA (2012)
A Case of Hereditary Xanthinuria Type 1 Accompanied by Bilateral Renal Calculi
Yutaka Fujiwara et al.
INTERNAL MEDICINE (2012)
Mutations Associated with Functional Disorder of Xanthine Oxidoreductase and Hereditary Xanthinuria in Humans
Kimiyoshi Ichida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
The First Mammalian Aldehyde Oxidase Crystal Structure INSIGHTS INTO SUBSTRATE SPECIFICITY
Catarina Coelho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Protein Conformational Gating of Enzymatic Activity in Xanthine Oxidoreductase
Hiroshi Ishikita et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Different inhibitory potency of febuxostat towards mammalian and bacterial xanthine oxidoreductases: insight from molecular dynamics
Hiroto Kikuchi et al.
SCIENTIFIC REPORTS (2012)
Molybdenum enzymes in higher organisms
Russ Hille et al.
COORDINATION CHEMISTRY REVIEWS (2011)
Nitrite reduction by xanthine oxidase family enzymes: a new class of nitrite reductases
Luisa B. Maia et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2011)
FYX-051: A Novel and Potent Hybrid-Type Inhibitor of Xanthine Oxidoreductase
Koji Matsumoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Uric Acid-Lowering Treatment With Benzbromarone in Patients With Heart Failure A Double-Blind Placebo-Controlled Crossover Preliminary Study
Kazuhide Ogino et al.
CIRCULATION-HEART FAILURE (2010)
Kinetics of 6-Thioxanthine Metabolism by Allelic Variants of Xanthine Oxidase
Mutsumi Kudo et al.
DRUG METABOLISM AND PHARMACOKINETICS (2010)
Xanthine dehydrogenase deficiency with novel sequence variations presenting as rheumatoid arthritis in a 78-year-old patient
Agnieszka Jurecka et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Low Serum Uric Acid Level Is a Risk Factor for Death in Incident Hemodialysis Patients
S. M. Kurt Lee et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase
Tomoko Nishino et al.
FEBS JOURNAL (2008)
Associations of hypertension and its complications with variations in the xanthine dehydrogenase gene
Jin Yang et al.
HYPERTENSION RESEARCH (2008)
The mechanism of assembly and cofactor insertion into Rhodobacter capsulatus xanthine dehydrogenase
Silvia Schumann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
Jon O. Lundberg et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Mechanism of inhibition of xanthine oxidoreductase by allopurinol: Crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinol
Ken Okamoto et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2008)
Functional characterization of human xanthine oxidase allelic variants
Mutsumi Kudo et al.
PHARMACOGENETICS AND GENOMICS (2008)
NADH oxidase activity of rat and human liver xanthine oxidoreductase: potential role in superoxide production
Luisa Maia et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2007)
Oxidation reaction by xanthine oxidase. Theoretical study of reaction mechanism
Tatsuo Amano et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Human xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site: Roles of active site residues in binding and activation of purine substrate
Yuichiro Yamaguchi et al.
JOURNAL OF BIOCHEMISTRY (2007)
Xanthinuria type I: a rare cause of urolithiasis
Nina Arikyants et al.
PEDIATRIC NEPHROLOGY (2007)
High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid
Jacob George et al.
CIRCULATION (2006)
The ubiquitous role of nitric oxide in cardioprotection
SP Jones et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
NADH oxidase activity of rat liver xanthine dehydrogenase and xanthine oxidase - contribution for damage mechanisms
L Maia et al.
FREE RADICAL RESEARCH (2005)
Mechanism of the conversion of xanthine dehydrogenase to xanthine oxidase - Identification of the two cysteine disulfide bonds and crystal structure of a non-convertible rat liver xanthine dehydrogenase mutant
T Nishino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Uric acid and oxidative stress
GK Glantzounis et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
CE Berry et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
Y-700 [1-[3-cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]:: A potent xanthine oxidoreductase inhibitor with hepatic excretion
A Fukunari et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The crystal structure of xanthine oxidoreductase during catalysis: Implications for reaction mechanism and enzyme inhibition
K Okamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Unique amino acids cluster for switching from the dehydrogenase to oxidase form of xanthine oxidoreductase
Y Kuwabara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Resonance Raman studies on xanthine oxidase:: observation of MoVI-ligand vibrations
NC Maiti et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2003)
An extremely potent inhibitor of xanthine oxidoreductase - Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition
K Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mutational analysis of the xanthine dehydrogenase gene in a Turkish family with autosomal recessive classical xanthinuria
F Gok et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II
K Ichida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Identification of a new point mutation in the human xanthine dehydrogenase gene responsible for a case of classical type I xanthinuria
N Sakamoto et al.
HUMAN GENETICS (2001)
Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: Structure-based mechanism of conversion
C Enroth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Antibacterial properties of xanthine oxidase in human milk
CR Stevens et al.
LANCET (2000)
A new route to peroxynitrite: a role for xanthine oxidoreductase
BLJ Godber et al.
FEBS LETTERS (2000)
XDH gene mutation is the underlying cause of classical xanthinuria:: A second report
D Levartovsky et al.
KIDNEY INTERNATIONAL (2000)
Analysis of the electron paramagnetic resonance properties of the [2Fe-2S]1+ centers in molybdenum enzymes of the xanthine oxidase family:: Assignment of signals I and II
J Caldeira et al.
BIOCHEMISTRY (2000)
Sequence motif-specific assignment of two [2Fe-2S] clusters in rat xanthine oxidoreductase studied by site-directed mutagenesis
T Iwasaki et al.
JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
